New Delhi, April 27 (IANS) India’s major drugmaker Sun Pharmaceutical Industries on Monday announced that it will acquire New York-listed Organon & Co in an all-cash deal valued at $11.75 billion, its biggest overseas acquisition to date.Under the agreement, the pharmaceutical firm will acquire 100 per cent of Organon’s outstanding shares at $14 per share, translating into an enterprise valuation of $11.75 billion and an equity value of around $3.99 billion, the company said in an exchan…
Trending
- Dose (2026) Movie Review: A Gripping Medical Thriller With a Powerful Core Concept
- Teesri Begum (2026) Review: A Bold Social Drama That Shines a Light on Deception and Resilience
- Purushaha Review: A Heartwarming Family Comedy That Keeps You Laughing
- Deool Band 2 Review: A Heartfelt Devotional Drama That Speaks to the Soul
- Ramani Kalyanam Review (2026) – A Heartfelt Tale of Love, Courage & Resilience
- Ugly Story (2026) Review: A Raw and Brave Telugu Film That Hits Hard
- War of Shera (Shera) Review: Parmish Verma Delivers a Powerful Revenge Drama That Hits All the Right Notes
- Desi Bling Review: Dubai’s Richest Indian Circles Bring Drama, Diamonds, and Addictive Chaos to Netflix